Eton Pharmaceuticals, Inc. Interest Expense
Eton Pharmaceuticals, Inc. (ETON) reported Interest Expense of $2.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. interest expense for the quarter ending 2026-06-30 was $1.01M, a 15.44% decline year-over-year.
- Eton Pharmaceuticals, Inc. interest expense for the quarter ending 2026-03-31 was $1.14M, a 2.32% decline year-over-year.
- Eton Pharmaceuticals, Inc. interest expense for the quarter ending 2025-09-30 was $1.21M, a 474.41% increase year-over-year.
- Eton Pharmaceuticals, Inc. interest expense for the quarter ending 2025-06-30 was $1.20M, a 439.64% increase year-over-year.
- Eton Pharmaceuticals, Inc. interest expense for fiscal 2023 was $1.06M, a 10.99% increase from fiscal 2022.
- Eton Pharmaceuticals, Inc. interest expense for fiscal 2022 was $955.00K, a 8.35% decline from fiscal 2021.
- Eton Pharmaceuticals, Inc. interest expense for fiscal 2021 was $1.04M, a 17.87% increase from fiscal 2020.
- Eton Pharmaceuticals, Inc. interest expense for fiscal 2020 was $884.00K, a 802.04% increase from fiscal 2019.
| Period end | Interest Expense 0 month | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.15M 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | $1.14M 10-Q · filed 2026-05-14 | ||||||
| 2025-09-30 | $1.21M 10-Q · filed 2025-11-06 | $2.41M derived: sum of 2 quarters · filed 2026-08-13 | $3.57M derived: sum of 3 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.36M 10-Q · filed 2026-08-13 | |||||
| 2025-03-31 | $1.16M 10-Q · filed 2026-05-14 | ||||||
| 2024-09-30 | $211.00K 10-Q · filed 2025-11-06 | $433.00K derived: sum of 2 quarters · filed 2025-11-06 | $672.00K 10-Q · filed 2024-11-12 | $926.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $460.00K 10-Q · filed 2025-08-07 | $715.00K derived: sum of 3 quarters · filed 2025-08-07 | $982.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $238.00K 10-Q · filed 2025-05-13 | $493.00K derived: sum of 2 quarters · filed 2025-05-13 | $760.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.03M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $522.00K derived: sum of 2 quarters · filed 2024-11-12 | $795.00K derived: sum of 3 quarters · filed 2024-11-12 | $1.06M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $267.00K 10-Q · filed 2024-11-12 | $805.00K 10-Q · filed 2023-11-09 | $540.00K derived: sum of 2 quarters · filed 2024-11-12 | $805.00K 10-Q · filed 2024-11-12 | $699.00K 10-Q · filed 2023-11-09 | $1.06M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $538.00K 10-Q · filed 2024-08-08 | $794.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.03M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $265.00K 10-Q · filed 2024-05-09 | $521.00K derived: sum of 2 quarters · filed 2024-05-09 | $754.00K derived: sum of 3 quarters · filed 2024-05-09 | $973.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $489.00K derived: sum of 2 quarters · filed 2024-03-14 | $708.00K derived: sum of 3 quarters · filed 2024-03-14 | $955.00K 10-K · filed 2024-03-14 | |||
| 2022-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $452.00K derived: sum of 2 quarters · filed 2023-08-10 | $699.00K 10-Q · filed 2022-11-10 | $975.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | $219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $466.00K 10-Q · filed 2023-08-10 | $742.00K derived: sum of 3 quarters · filed 2024-03-14 | $995.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | $247.00K 10-Q · filed 2023-05-11 | $523.00K derived: sum of 2 quarters · filed 2024-03-14 | $776.00K derived: sum of 3 quarters · filed 2024-03-14 | $1.02M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $529.00K derived: sum of 2 quarters · filed 2024-03-14 | $778.00K derived: sum of 3 quarters · filed 2024-03-14 | $1.04M 10-K · filed 2024-03-14 | |||
| 2021-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $502.00K derived: sum of 2 quarters · filed 2022-11-10 | $766.00K 10-Q · filed 2022-11-10 | $1.03M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $513.00K 10-Q · filed 2022-08-11 | $780.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.01M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-03-31 | $264.00K 10-Q · filed 2022-05-12 | $531.00K derived: sum of 2 quarters · filed 2023-03-16 | $762.00K derived: sum of 3 quarters · filed 2023-03-16 | $953.00K derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2020-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $498.00K derived: sum of 2 quarters · filed 2023-03-16 | $689.00K derived: sum of 3 quarters · filed 2023-03-16 | $884.00K 10-K · filed 2023-03-16 | |||
| 2020-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | $422.00K derived: sum of 2 quarters · filed 2021-11-16 | $617.00K 10-Q · filed 2021-11-16 | ||||
| 2020-06-30 | $191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $386.00K 10-Q · filed 2021-08-16 | |||||
| 2020-05-04 | $1.00K 10-Q · filed 2020-08-12 | ||||||
| 2020-03-31 | $195.00K 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | $98.00K 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |